Lymphedema

OTC Braces & Supports Market worth $1,286 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
木曜日, 10月 6, 2022
Knowledge, Adoption, Insurance, Wrist, Compression, Risk, DJO Global, Growth, Pharmacy, Stocking, Mouth ulcer, CAGR, Intelligence, Hospital, Human, Research, DVT, Static, Spine, Sport, Knee, Elbow, Anterior cruciate ligament injury, Brace, Motion, Gesellschaft mit beschränkter Haftung, Awareness, GEM, Ankle, OTC, Lists of countries and territories, Hip, Osteoarthritis, Shoulder, Femoral vein, USD, SME, Clothing, Dentistry, Distribution (marketing), Marketing, Pump, Lymphedema, Wrap (food), Bandage

Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.

Key Points: 
  • Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.
  • The knee braces and supports segment had the major share of the OTC braces and supports Market, by product, in 2021"
    Based on product, the OTC braces and supports market is divided into knee, ankle; back, hip, & spine; foot walkers and orthoses; hand & wrist; shoulder; elbow; and facial braces and supports.
  • In 2021, preventive care segment accounted for the largest share in the market, by application"
    Based on the application, the OTC braces and supports market is segmented into preventive care, ligament injury, osteoarthritis, compression therapy, and other applications.
  • The global otc braces and supports market is segmented into five major regions namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease

Retrieved on: 
火曜日, 10月 4, 2022
Health, FDA, Medical Devices, Technology, Mobile, Wireless, General Health, Clinical Trials, Scientific Reports, ACPD, AVLS, Medicare, Medicine, Edema, Dayspring, Lymphedema, Effectiveness, HCPCS, Food, CEO, Safety, FDA, Center, DME, Centers for Medicare & Medicaid Services, Swelling, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Journal, Patient, NILE, Randomness, Extremities, Woman, CMS, Pharmaceutical industry, Medical device, Nature

Dayspring is the first non-pneumatic active dynamic compression treatment designed for patient mobility and cleared by the U.S. Food and Drug Administration (FDA) to treat lymphedema and chronic venous conditions.

Key Points: 
  • Dayspring is the first non-pneumatic active dynamic compression treatment designed for patient mobility and cleared by the U.S. Food and Drug Administration (FDA) to treat lymphedema and chronic venous conditions.
  • We are thrilled to expand access to more treatment choices for people living with lymphedema and chronic venous conditions.
  • These key data publications further expand our body of clinical evidence supporting the use of the Dayspring active compression system for people living with lymphedema and chronic venous conditions, said Thomas Maldonado, M.D., medical director of the Venous Thromboembolic Center at New York University Langone Health.
  • These results highlight the significant benefits the Dayspring system provides in the way we can manage and treat lymphedema and venous disease.

ImpediMed Announces U.S. Launch of Lymphedema Prevention Program with GenesisCare a Global Organization Dedicated to Care of Cancer Patients

Retrieved on: 
火曜日, 10月 4, 2022
Solution, Radiation, Cancer, Time, Skin, Research, Lymphedema, MD, Multimedia, GenesisCare, FDA, Patient, Strathcona County, Swelling, Quality of life, Breast cancer, Internationalized domain name, Heart failure, Interim, IDN, Lymphatic system, Risk, Organization, BIS, Company, Airline, Medicine, Pharmaceutical industry

ImpediMed is pleased to announce a Global Strategic Commercial Partnership and SOZO pilot program with GenesisCare.

Key Points: 
  • ImpediMed is pleased to announce a Global Strategic Commercial Partnership and SOZO pilot program with GenesisCare.
  • GenesisCare is a global care leader with more than 6,000 highly trained healthcare professionals employed at more than 300 locations across four countries.
  • They are the one of largest providers of cancer care in USA, Australia, Spain, and the UK.
  • These initial programs will create the template to bring lymphedema prevention services to more cancer patients across the globe."

JET LINX CELEBRATES 10th ANNIVERSARY OF THE TUTU PROJECT

Retrieved on: 
月曜日, 10月 3, 2022
Linx, Aircraft, Linda, Food, Lists of stars, Transport, NE, Lymphedema, Man, CEO, Multimedia, View, Foundation, Friends, Insurance, Tutu, Partnership, Forbes Travel Guide, ISO 639:b, Breast cancer, Sale, Patient, Diagnosis, Travel, Love, Organization, Jet card, Woman, Shop, Company, Awareness, Airline, 3D printing

OMAHA, Neb., Oct. 3, 2022 /PRNewswire/ -- Jet Linx, the only locally-focused, global private aviation company providing Aircraft Management, Joint Ownership and Jet Card Membership services through its 21 locations nationwide, today announced its eighth consecutive year of support as lead corporate sponsor for The Tutu Project, an initiative of The Carey Foundation. In 2022, The Tutu Project celebrates 10 years in operation as a 501(c)(3) nonprofit. Proceeds from the initiative provide everything from wigs and lymphedema sleeves to transportation, childcare, and counseling to the families impacted by a breast cancer diagnosis.

Key Points: 
  • In 2022, The Tutu Project celebrates 10 years in operation as a 501(c)(3) nonprofit.
  • Since 2015, Jet Linx has supported The Tutu Project through the #Dare2Tutu challenge, wherein the Company matches $10 in exchange for an image of a person wearing a pink tutu.
  • The images with over 12,000 #Dare2Tutu images captured to date are shared on Jet Linx social media channels to raise awareness.
  • Jet Linx encourages all friends and clients to participate in this year's #Dare2Tutu campaign, celebrating the nonprofit's 10th year of tulle-filled success.

ImpediMed Announces Two Posters at Heart Failure Society of America Annual Scientific Meeting That Demonstrate Utility of SOZO® Digital Health Platform for Heart Failure Patients

Retrieved on: 
金曜日, 9月 30, 2022
Hospital, Health, ASX, Heart Failure Society of America, Risk, FDA, Lymphedema, Poster, Scripps Health, Heart failure, Patient, Decompensation, BIS, Interim, Research, IPD, Multimedia, Emergency medicine, Education, Blood, Medical device, Medical imaging, Pharmaceutical industry

The study evaluated one-time SOZO Digital Health Platform BIS measurements using ImpediMed's HF-Dex heart failure index of heart failure patients compared to non-heart failure patients.

Key Points: 
  • The study evaluated one-time SOZO Digital Health Platform BIS measurements using ImpediMed's HF-Dex heart failure index of heart failure patients compared to non-heart failure patients.
  • The study analyzed SOZO Digital Health Platform BIS measurements compared to the heart failure specialist's expert assessment of fluid volume and decision to adjust medication.
  • "It is an honor to have our posters presented by the Heart Failure Society of America at its Annual Scientific Meeting.
  • The SOZO fluid analysis for heart failure provides an objective measure of fluid volume in heart failure patients.

Texas Physical Therapy Specialists Opens New Clinic in Deerfield

Retrieved on: 
月曜日, 9月 26, 2022
AlterG, Health, Athlete, Movement, Temporomandibular joint dysfunction, Accident, DPT, Lymphedema, OCS, Patient, Facebook, PT, Evidence-based practice, Sport, Family, Chronic pain, Research, Pelvic floor, Medicine, TMJ

LOUISVILLE, Ky., Sept. 26, 2022 /PRNewswire-PRWeb/ -- Texas Physical Therapy Specialists (TexPTS) is pleased to announce their newest clinic has opened today in San Antonio, TX. Located at 16625 Huebner Road, the clinic is TexPTS' 42nd location.

Key Points: 
  • LOUISVILLE, Ky., Sept. 26, 2022 /PRNewswire-PRWeb/ -- Texas Physical Therapy Specialists (TexPTS) is pleased to announce their newest clinic has opened today in San Antonio, TX.
  • Zachary Kovacevic, PT, DPT, OCS, will serve as the Deerfield Clinic Director and primary treating physical therapist.
  • Services offered from the Deerfield clinic will include manual and orthopedic physical therapy, sports & performance therapy, training breast cancer & oncology, chronic pain, lymphedema, pelvic floor & women's health, podiatry issues, post-COVID therapy, telehealth services, TMJ disorder, vestibular imbalance, and weight loss/metabolic conditions.
  • Texas Physical Therapy Specialists (TexPTS) is a Texas-based, private physical therapy practice group.

Tactile Medical to Release Third Quarter of Fiscal Year 2022 Financial Results on November 7, 2022

Retrieved on: 
月曜日, 9月 26, 2022
Lymphedema, Lipedema, Chronic venous insufficiency, GLOBE, Company, Patient, Marketing, Degenerative disease, Awareness, Quality of life, Webcast, Conditional sentence, TCMD, Medical device, Pharmaceutical industry

MINNEAPOLIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (Tactile Medical) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that third quarter of fiscal year 2022 financial results will be released after the market closes on Monday, November 7th.

Key Points: 
  • MINNEAPOLIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (Tactile Medical) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that third quarter of fiscal year 2022 financial results will be released after the market closes on Monday, November 7th.
  • Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on November 7th to discuss the results of the quarter.
  • Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13733034.
  • A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.

InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

Retrieved on: 
金曜日, 9月 23, 2022
Oncology, Medical Supplies, Medical Devices, Health, Physical Therapy, Managed Care, Computer science, Securities Exchange Act of 1934, Lauder, University, COVID-19, NYSE, Economics, Employee Retirement Income Security Act of 1974, ITS, Contract, Company, Growth, Form 10-K, Wharton School of the University of Pennsylvania, Partnership, Securities Act of 1933, Excellent, Forward-looking statement, Investment, Risk, Pain management, International relations, Founder, Johns Hopkins University, Lymphedema, Share repurchase, Board, Form 10-Q, Annual report, Risk management

Scott Shuda, Chairman of InfuSystems Board of Directors, said, We are pleased to welcome Rimmy as a new independent director on InfuSystems Board.

Key Points: 
  • Scott Shuda, Chairman of InfuSystems Board of Directors, said, We are pleased to welcome Rimmy as a new independent director on InfuSystems Board.
  • Rimmy first invested in the Company in 2012, and has an earned reputation as a particularly attentive shareholder.
  • I have long admired InfuSystem, and believe the Company has opportunity to significantly expand its business to the benefit of all stakeholders, said Mr. Malhotra.
  • Since November 2019, Mr. Malhotra has been a member of the Board of Directors of Optex Systems Holdings, Inc., an optical systems manufacturer, and also sits on the board of Scotts Liquid Gold.

InfuSystem to Participate in Lake Street’s 6th Annual Best Ideas Growth (BIG6) Conference September 14, 2022

Retrieved on: 
水曜日, 9月 7, 2022
Medical Supplies, Medical Devices, Health, Surgery, Other Health, Pharmaceutical, Yale Club of New York City, Excellent, COVID-19, NYSE, Securities Exchange Act of 1934, Securities Act of 1933, Form 10-K, Lymphedema, Risk, Share repurchase, Employee Retirement Income Security Act of 1974, Forward-looking statement, Form 10-Q, ITS, Conference, Company, Pain management, Annual report, Contract, Lake Street

The conference is being held at The Yale Club in New York City.

Key Points: 
  • The conference is being held at The Yale Club in New York City.
  • To receive additional information, request an invitation or to schedule a one-on-one meeting, please email [email protected] .
  • Lake Street will host its 6th Annual Best Ideas Growth (BIG6) Conference at the Yale Club in New York.
  • BIG is our annual signature event, featuring dynamic public companies across multiple sectors, paired with world-class institutional investors, in a one-on-one meeting format.

Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery

Retrieved on: 
水曜日, 9月 7, 2022
Artery, Lymphedema, CEO, Cancer, RA, DDS, Oral, Hand, Suture, Oral and maxillofacial surgery, Robotics, Supermicro, Tongue, Department, Union, Microsurgery, Vein, MD, Surgeon, Frasier, MMI, Patient, Dentistry, EU, Biostar

PISA, Italy, Sept. 7, 2022 /PRNewswire/ -- Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and dilator were recently used in clinical procedures in Zürich, Florence, and Salzburg, with successful patient outcomes.

Key Points: 
  • "We've already seen the benefits of Symani and the NanoWrist instruments in improving dexterity and control," said Dr. Enzinger.
  • "The new supermicro instrument tips are even smaller and more refined, making it significantly easier to precisely connect vessels under one millimeter in diameter.
  • Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.
  • The Symani Surgical System combines proprietary innovations including the world's smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies.